Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
Authors
Keywords
Cancer stem cells, Non-small cell lung cancer, Gene expression, Somatostatin, Epithelial cells, Stem cell therapy, Breast cancer, Drug delivery
Journal
PLoS One
Volume 12, Issue 5, Pages e0178286
Publisher
Public Library of Science (PLoS)
Online
2017-05-23
DOI
10.1371/journal.pone.0178286
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging
- (2016) Nithya Subramanian et al. Molecular Therapy-Nucleic Acids
- Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination
- (2015) Nuno A. Fonseca et al. BIOMATERIALS
- Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma
- (2015) Jun Hu et al. Chemistry-An Asian Journal
- Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach
- (2015) Sarandeep Malhi et al. Expert Opinion on Drug Delivery
- Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation
- (2015) E. Merit Reyes-Reyes et al. Molecular Oncology
- Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
- (2015) Ling-Yen Chung et al. Oncotarget
- Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) M. Reck et al. ANNALS OF ONCOLOGY
- Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
- (2014) Yinan Zhong et al. BIOMACROMOLECULES
- Peptide receptor therapies in neuroendocrine tumors
- (2014) L. Bodei et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Evaluation of Cobalt-Labeled Octreotide Analogs for Molecular Imaging and Auger Electron-Based Radionuclide Therapy
- (2014) H. Thisgaard et al. JOURNAL OF NUCLEAR MEDICINE
- Cancer stem cell detection and isolation
- (2014) Meysam Moghbeli et al. MEDICAL ONCOLOGY
- Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors
- (2014) Ebrahim S. Delpassand et al. PANCREAS
- Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
- (2014) Marina Koutsioumpa et al. Recent Patents on Anti-Cancer Drug Discovery
- Multifunctional Nucleic Acids for Tumor Cell Treatment
- (2014) Monika Pofahl et al. Nucleic Acid Therapeutics
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells
- (2013) Monica Charpentier et al. Cancers
- Heat Shock Cognate 70 Regulates the Translocation and Angiogenic Function of Nucleolin
- (2012) Yanping Ding et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Future of Peptide-based Drugs
- (2012) David J. Craik et al. Chemical Biology & Drug Design
- MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy
- (2011) Yun Wu et al. MOLECULAR PHARMACEUTICS
- Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice
- (2010) Diala El Khoury et al. BMC CANCER
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now